Healthcare News Options
Novo CEO pressed by Senate to cut prices of being overweight, diabetes medication CEO Lars Fruergaard Jørgensen instructed lawmakers the corporation would think about new talks with insurers with regards to the list rates of Wegovy and copyright should they pledge to help keep the medicines on their own formularies.The deal should be finished by S